Work Here?
Overview
Fabric Genomics provides AI-powered genomic analysis and reporting for hospitals, research institutions, and diagnostic labs through a software-as-a-service platform. It analyzes Next-Generation Sequencing data, including whole genomes, exomes, and gene panels, and uses the Fabric GEM AI to interpret variants and generate clinical reports, with automated reanalysis to revisit undiagnosed cases over time. The service differentiates itself with AI-driven interpretation, support for multiple NGS types, and continuous reanalysis delivered via a scalable SaaS model. The goal is to help clinicians diagnose genetic conditions more quickly and accurately while lowering the time and cost of genomic testing.
About Fabric Genomics
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series B
Total Funding
$29.8M
Headquarters
San Francisco, California
Founded
2009
Simplify's Take
What believers are saying
- GeneDx acquisition in April 2025 boosts clinical expertise and global scale.
- Partnerships with Intermountain and Plumcare expand NICU and newborn screening.
- Software deals with Oxford Nanopore and DNAnexus enhance long-read compatibility.
What critics are saying
- GeneDx integration dilutes Fabric's autonomous AI innovation within 6-12 months.
- Illumina-Veracyte bundles displace Fabric's standalone SaaS in hospitals.
- CMS reimbursement caps compress NICU WGS margins in 12-18 months.
What makes Fabric Genomics unique
- Fabric GEM AI algorithm automates reanalysis of undiagnosed genomic cases.
- Selected as primary interpreter for UK's 100,000 Genomes Project in 2015.
- Achieves 54% causative yields in whole genome analysis for top organizations.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$29.8M
Below
Industry Average
Funded Over
2 Rounds
Industry standards
Benefits
Competitive compensation
Health benefits and coverage
PTO
Parental leave
Growth & Insights and Company News
6 month growth
↑ 3%1 year growth
↑ 3%2 year growth
↑ 3%Galatea Bio, Fabric Genomics partner to develop genetic disease risk assays.
GeneDx (Nasdaq: WGS) today announced the successful completion of its acquisition of Fabric Genomics, a pioneer in AI-powered genomic interpretation.
GeneDx has completed its acquisition of Fabric Genomics, enhancing its capabilities in genomic medicine by integrating Fabric's AI-powered genomic interpretation. This merger aims to improve global healthcare by offering centralized and decentralized genomic insights, facilitating earlier and more accurate diagnoses. Fabric Genomics will continue as a subsidiary of GeneDx, leveraging GeneDx's clinical expertise and Fabric's advanced technology to set new standards in genomic diagnostics.
NEW YORK - GeneDx said Wednesday that it plans to acquire Fabric Genomics for $33 million in cash with the potential consideration rising to $51 million if certain milestones are met.
GeneDx plans to acquire Fabric Genomics, enhancing its leadership in genomic medicine by integrating AI-powered genomic interpretation. This acquisition supports decentralized testing with centralized intelligence, allowing health systems to use GeneDx’s lab or perform sequencing in-house. Fabric Genomics' AI platform aids in interpreting complex genetic cases, facilitating better clinical outcomes globally.
There are no jobs for Fabric Genomics right now.
Find jobs on Simplify and start your career today
About Fabric Genomics
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series B
Total Funding
$29.8M
Headquarters
San Francisco, California
Founded
2009
There are no jobs for Fabric Genomics right now.
Find jobs on Simplify and start your career today